CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve aerosol drug delivery to the lungs for treating respiratory diseases. It focuses on developing a novel nebulization method to enhance medication deposition and reduce side effects, ultimately advancing therapeutic options for respiratory conditions.
Respiratory diseases are one of the leading causes of death worldwide.
The recent global pandemic of severe acute respiratory syndrome (SARS-CoV-2) has made us realize that effective and widely acceptable therapies against such diseases are still lacking and urgently needed.
Administering drugs through aerosolization directly to the lungs, i.e. pulmonary delivery, enables targeted therapeutic effects while minimizing side effects by reducing systemic drug exposure.
However, generically aerosol d…
UNIVERSITEIT VAN AMSTERDAM
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Enschede
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
